No Data
The Nikkei average is up about 660 yen, after a round of buying, selling has made it difficult to rise further as it awaits a pullback = morning session on the 13th.
On the 13th, shortly after 10:03 AM, the Nikkei average stock price was around 38,300 yen, up approximately 660 yen compared to the previous day. It has been about a month and a half since the stock price reached the 38,000 yen level during trading hours, last seen on March 26. At 9:06 AM, it reached a high of 38,494.06 yen, up 849.80 yen. In the U.S. stock market on the 12th, there was a positive reaction to the agreement to reduce the additional tariffs imposed by both countries by 115% in the U.S.-China trade talks, leading to a sharp rebound in the Dow Inc and the Nasdaq Composite Index.
List of conversion stocks (Part 2) [Parabolic Signal conversion stocks list]
○ List of stocks changing to Sell market Code Stock Name Closing Price SAR Main Board <1414> ShoBond 4988 5339 <1813> Fudo Tetra 22032391 <2154> Open UP 17771890 <2201> Morinaga Confectionery 25002606 <2229> Calbee 28972943 <2282> Nippon Ham 53245530 <2325> NJS 39454215 <2378> Renaissance
ADR trends on the 12th = Takeda Pharmaceutical, Daiichi Sankyo, IHI, ETC are high in yen conversion values.
On the 12th, the American Depositary Receipts (ADRs) were generally higher compared to the closing prices in Tokyo, when converted to yen. In yen terms, Takeda Pharmaceutical <4502.T>, Daiichi Sankyo <4568.T>, IHI <7013.T>, HOYA <7741.T>, SoftBank Group <9984.T>, etc. showed a rise. Furukawa Electric <5801.T>, Advantest <6857.T>, Nissan Motor <7201.T>, Tokyo Electron <8035.T>, Mitsubishi UFJ <8306.T>, etc. also performed well. Provided by Wealthad.
Global Pharma Stocks Fall as Trump Plans to Cut Drug Prices
Spot information on individual stocks (2)
Kawata TECH <3443.T> updates its high price. It has become clear that the management company fundnote holds 5.94% of the company's Stocks. Encho <8208.T> is in a situation of a limit-up order. DCM <3050.T> has concluded a stock exchange contract. Geo HD <2681.T> has sharply declined. The consolidated performance for the current March period is expected to have only a slight increase in operating profit. Japan Hospice <7061.T> is in a situation of a limit-down order. The first quarter (January-March) consolidated performance for the current December period shows a significant decrease in operating profit. Chugai Pharmaceutical <
Evaluate the progress of negotiations in the US-China agreement.
The Nikkei average continued to rise, finishing the Trade at 37,644.26 yen, up 140.93 yen (with an estimated Volume of 2.1 billion 50 million shares). The Trade began with Buy interest as the first ministerial-level talks between the USA and China on trade issues progressed. The index extended its gains to 37,726.44 yen shortly after the opening. However, some Sell orders emerged to secure profits from the rapid rise, gradually narrowing the gains, and shortly after the opening of the afternoon session, it turned negative at 37,417.39 yen. However, the USA Futures on Globex remained strong.
